TIMP-1 protein found to boost immune system’s fight against cancer

FHS
June 14, 2024
3:53 pm

Researchers at the University of Turku in Finland have found a new function for an existing protein.

Safety, efficacy and dosing questions linger for Lilly’s Alzheimer’s drug ahead of Monday adcomm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 7, 2024

Gerresheimer makes solid start to the financial year 2024 – Biotech Investments

EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement Gerresheimer makes solid start to the financial year 2024 11.04.2024 / 07:00 CET/CEST The issuer

April 12, 2024

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.